Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2023 Jul 25;23:697. doi: 10.1186/s12885-023-11206-5

Correction: Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma

Qingwu Du 1,#, Xiaoyue Wu 1,#, Kunning Zhang 1, Fuliang Cao 2, Gang Zhao 3, Xiaoying Wei 1, Zhoubo Guo 1, Yang Li 1, Jie Dong 4, Tian Zhang 1, Wencheng Zhang 1, Ping Wang 1,✉, Xi Chen 1,✉, Qingsong Pang 1,✉
PMCID: PMC10367337  PMID: 37491217

Correction: BMC Cancer 23, 681 (2023)

https://doi.org/10.1186/s12885-023-10803-8

Following publication of the original article [1], the authors identified that the versions of Fig. 2 and Fig. 4 are incorrect. The figures published in this correction article are correct and the original article [1] has been corrected.

Fig. 2.

Fig. 2

Distributions of tumor remission (A), tumor thickness (B) and lumen involvement (C) at baseline and during treatment between responders and non-responders

Fig. 4.

Fig. 4

Construction and validation of the nomogram for predicting PFS and OS. The nomogram for predicting 1-, 2-, and 3-year PFS (A) and OS (D) of patients with ESCC. Time-dependent ROC curves of the nomogram for PFS (B, C) and OS (E, F) prediction in the training and the testing cohorts. Abbreviations: ER, excellent remission; SLI, spatial luminal involvement; PFS, progression-free survival; OS, overall survival

Footnotes

Qingwu Du and Xiaoyue Wu contributed equally to this work.

Contributor Information

Ping Wang, Email: wangping@tjmuch.com.

Xi Chen, Email: chenxitj@tmu.edu.cn.

Qingsong Pang, Email: pangqingsong@tjmuch.com.

Reference

  • 1.Du Q, Wu X, Zhang K, et al. Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma. BMC Cancer. 2023;23:681. doi: 10.1186/s12885-023-10803-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES